GLP-1 Diabetes Drugs Linked to Notable Drop in Addiction Rates

TL;DR
A UT El Paso study of more than 142,000 adults with type 2 diabetes or obesity found that GLP-1 medications (including Ozempic) were associated with substantially lower rates of several substance-use disorders—74% lower for alcohol, 69% for opioid, 68% for nicotine, and 75% for cocaine—compared with similar patients not on GLP-1s. Researchers caution that this is observational and not proof of prevention; randomized trials are needed, and the team plans prospective studies to see if GLP-1 therapy changes substance use and mental health outcomes.
- Ozempic and Similar Drugs Linked to Dramatic Drop in Addiction Rates SciTechDaily
- Arizona treatment center using weight loss meds in addiction recovery AZ Family
- UW drug trial tests a GLP-1 treatment for alcohol addiction KNKX
- New UTEP study shows Ozempic may help curb substance abuse KVIA
- Ozempic and similar drugs tied to lower rates of alcohol, opioid, nicotine, and cocaine use Yahoo
Want the full story? Read the original reporting
Read on SciTechDaily